Nonalcoholic Fatty Liver Disease
Cumulative incidence rate for serious infection in NAFLD nears 50% over 20 years
Patients with nonalcoholic fatty liver disease had a significantly greater risk for severe infection requiring hospitalization vs. the general population, with an absolute risk difference of more than 17%at 20 years after diagnosis.
Bariatric surgery may lower risk for cardiovascular events, mortality in NAFLD, obesity
Bariatric surgery was linked to a decreased risk for major adverse cardiovascular events and all-cause mortality among patients with nonalcoholic fatty liver disease and obesity, according to results in JAMA Network Open.
Rise in NAFLD in pregnancy has ‘huge national implications,’ highlights need for detection
The prevalence of nonalcoholic fatty liver disease was 14% among pregnant women screened during early pregnancy, with fewer than 5% receiving prior evaluation for NAFLD, according to research in Clinical Gastroenterology and Hepatology.
High mortality rates prove lean patients with NAFLD should ‘be taken seriously’
Lean patients with nonalcoholic fatty liver disease had significantly higher mortality than non-lean patients, despite having lower rates of cirrhosis and diabetes, according to research in Alimentary Pharmacology & Therapeutics.
People with NAFLD who exercise are 3.5 times more likely to achieve liver fat reduction
Physically active patients with nonalcoholic fatty liver disease were more likely to achieve at least a 30% reduction in MRI-measured liver fat, according to research in The American Journal of Gastroenterology.
To reach consensus on NAFLD nomenclature, evaluation process must be democratic
I never would have thought the debate on nonalcoholic fatty liver disease nomenclature would be as contentious as it is.
To focus solely on NAFLD nomenclature, not patient care, is ‘ultimately detrimental’
This exercise about nonalcoholic fatty liver disease nomenclature is a distraction from what patients really care about.
Possible NAFLD name change must benefit both patients, field of hepatology
Regarding the nonalcoholic fatty liver disease nomenclature debate, I am pretty neutral to what the new name should be, and I want to be sensitive to all parties involved.
New name for NAFLD may not be better, process may become ‘endless debate’
Many health care providers agree the term nonalcoholic fatty liver disease is a bad name because it’s defining a disease by what it is not; however, the challenge has been to find something that would fulfill a number of criteria.
If not careful, NAFLD name change may damage decades of research on the disease
The term nonalcoholic fatty liver disease has been around for almost three decades and it is an imperfect term, because it uses two controversial words: “nonalcoholic” and “fatty”.